Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio (2020 - 2024)
Ginkgo Bioworks Holdings' (DNA) quarterly Interest Coverage Ratio came in at 3.3 in Q4 2024, up 18.4% on a YoY basis from 2.79 in Q1 2024, and down 155.35% quarter-over-quarter from 5.97 in Q3 2024.
Analysis
Ginkgo Bioworks Holdings (DNA) Interest Coverage Ratio (2020 - 2024) Analysis & Trends
Ginkgo Bioworks Holdings (DNA) has reported Interest Coverage Ratio for 4 consecutive years, with 3.3 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Interest Coverage Ratio rose 18.4% year-over-year to 3.3; the trailing twelve-month figure through Dec 2024 stood at 10.03 (up 82.38% YoY), and the FY2024 full-year result was 5954.86, up 35.93% from the prior year.
- Interest Coverage Ratio declined to 3.3 in Q4 2024 per DNA's latest filing, from 5.97 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 21.62 in Q2 2024 and bottomed at 3057.6 in Q4 2021.
- Historically, Interest Coverage Ratio has averaged 319.94 across 4 years, with a median of 3.68 in 2023.
- The sharpest annual moves came in 2021 and 2024: Interest Coverage Ratio plunged 3127.85% in 2021, then jumped 68.45% in 2024.
- Over 4 years, Interest Coverage Ratio stood at 94.73 in 2020, then slumped by 3127.85% to 3057.6 in 2021, then jumped by 99.87% to 4.05 in 2023, then climbed by 18.4% to 3.3 in 2024.
- According to Business Quant data, Interest Coverage Ratio over the past three periods registered 3.3, 5.97, and 21.62 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 2.57 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | - |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.83 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 3.95 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | - |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | - |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -689.75 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -3.30 |
| Sep 30, 2024 | 5.97 |
| Jun 30, 2024 | 21.62 |
| Dec 31, 2023 | -4.05 |
| Sep 30, 2023 | 19.07 |
| Jun 30, 2023 | 12.83 |
| Dec 31, 2021 | -3,057.60 |
| Sep 30, 2021 | -41.10 |
| Dec 31, 2020 | -94.73 |
| Sep 30, 2020 | -58.13 |